Sequence Bio logo

Sequence Bio

Discovering the true signals of disease to power life-changing drugs.

Summer 2019Healthcare / Healthcare -> Drug Discovery and DeliverySt. John's, NL, Canada52 employees
Genomics
Therapeutics
Drug discovery

About

90% of drug candidates fail, delaying help for those in need. We’re on a mission to change that. Better drug target discovery powered by the Newfoundland founder effect.

Build your own investing agent

GPAgent keeps YC listings public and neutral. Fund-specific scoring, notes, and workflow state live in each customer workspace.

Join the GPAgent waitlist

Founders (2)

Chris Gardner
Founder
Jeremy Grushcow
Founder

Details

Status
Active
Stage
Early
Team Size
52
Regions
Canada, America / Canada, Remote, Partly Remote